| Trial registration number
|
IRCT20190804044429N6 |
Full text link
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/54008
|
First author
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Majid Saeedi
|
Contact
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
majsaeedi@gmail.com
|
Registration date
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-02-20
|
Recruitment status
Last imported at : April 18, 2021, 9:33 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Inclusion criteria are adults over the age of 18 with a diagnosis of COVID-19 based on clinical criteria (presence of any symptoms of cough, shortness of breath, fever, and CT scan of the lung for evidence of involvement consistent with COVID-19 infection) or PCR and
had an olfactory dysfunction ( reduced or loss of sense of smell) for two weeks
|
Exclusion criteria
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Pregnancy and lactation
History of olfactory dysfunction
Taking drugs that affect the olfactory disorders
Corticosteroids chronic use
Nasal anatomic dysfunction
Existence of dry ducts or nasal bleeding
Existence of herpetic lesion
Dissatisfaction with participating in the study
|
Number of arms
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mazandaran University of Medical Sciences
|
Inclusion age min
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
No restriction on type of patients
|
Severity scale
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
0: No restriction on type of patients
|
Total sample size
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
60
|
primary outcome
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Olfactory symptoms improvement
Safety of mometasone nasal spray
|
Notes
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 2/Phase 3
|
Arms
Last imported at : Feb. 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 815, "treatment_name": "Mometasone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|